» Articles » PMID: 24964958

Discovery of Novel Schistosoma Japonicum Antigens Using a Targeted Protein Microarray Approach

Overview
Journal Parasit Vectors
Publisher Biomed Central
Date 2014 Jun 27
PMID 24964958
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Novel vaccine candidates against Schistosoma japonicum are required, and antigens present in the vulnerable larval developmental stage are attractive targets. Post-genomic technologies are now available which can contribute to such antigen discovery.

Methods: A schistosome-specific protein microarray was probed using the local antibody response against migrating larvae. Antigens were assessed for their novelty and predicted larval expression and host-exposed features. One antigen was further characterised and its sequence and structure were analysed in silico. Real-time polymerase chain reaction was used to analyse transcript expression throughout development, and immunoblotting and enzyme-linked immunosorbent assays employed to determine antigen recognition by antibody samples.

Results: Several known and novel antigens were discovered, two of which showed up-regulated transcription in schistosomula. One novel antigen, termed S. japonicum Ly-6-like protein 1 (Sj-L6L-1), was further characterised and shown to share structural and sequence features with the Ly-6 protein family. It was found to be present in the worm tegument and expressed in both the larval and adult worms, but was found to be antigenic only in the lungs that the larvae migrate to and traverse.

Conclusions: This study represents a novel approach to vaccine antigen discovery and may contribute to schistosome vaccine development against this important group of human and veterinary pathogens.

Citing Articles

Trematode Genomics and Proteomics.

Rinaldi G, Loukas A, Sotillo J Adv Exp Med Biol. 2024; 1454:507-539.

PMID: 39008274 DOI: 10.1007/978-3-031-60121-7_13.


Schistosoma mansoni vaccine candidates identified by unbiased phage display screening in self-cured rhesus macaques.

Woellner-Santos D, Tahira A, Malvezzi J, Mesel V, Morales-Vicente D, Trentini M NPJ Vaccines. 2024; 9(1):5.

PMID: 38177171 PMC: 10767053. DOI: 10.1038/s41541-023-00803-x.


Anti-schistosomal immunity to core xylose/fucose in N-glycans.

Prasanphanich N, Leon K, Evan Secor W, Shoemaker C, Heimburg-Molinaro J, Cummings R Front Mol Biosci. 2023; 10:1142620.

PMID: 37081851 PMC: 10110957. DOI: 10.3389/fmolb.2023.1142620.


Silencing of Tetraspanin Gene Expression Results in Reduced Secretion of Extracellular Vesicles.

Chaiyadet S, Sotillo J, Krueajampa W, Thongsen S, Smout M, Brindley P Front Cell Infect Microbiol. 2022; 12:827521.

PMID: 35223551 PMC: 8875506. DOI: 10.3389/fcimb.2022.827521.


Molecular Characterization of a Tetraspanin TSP11 Gene in and Evaluation Its Immunoprotection in Model Dogs.

Xian J, Zhao P, Wang N, Wang W, Zhang Y, Meng J Front Vet Sci. 2021; 8:759283.

PMID: 34869731 PMC: 8635718. DOI: 10.3389/fvets.2021.759283.


References
1.
Gobert G, Moertel L, Brindley P, McManus D . Developmental gene expression profiles of the human pathogen Schistosoma japonicum. BMC Genomics. 2009; 10:128. PMC: 2670322. DOI: 10.1186/1471-2164-10-128. View

2.
Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M . Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002; 18 Suppl 1:S96-104. DOI: 10.1093/bioinformatics/18.suppl_1.s96. View

3.
. The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature. 2009; 460(7253):345-51. PMC: 3747554. DOI: 10.1038/nature08140. View

4.
Driguez P, Doolan D, Loukas A, Felgner P, McManus D . Schistosomiasis vaccine discovery using immunomics. Parasit Vectors. 2010; 3:4. PMC: 2837634. DOI: 10.1186/1756-3305-3-4. View

5.
Bamezai A . Mouse Ly-6 proteins and their extended family: markers of cell differentiation and regulators of cell signaling. Arch Immunol Ther Exp (Warsz). 2004; 52(4):255-66. View